Greenbrook TMS (Greenbrook TMS) Short Interest

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Greenbrook TMS's Short Interest

For the Medical Care Facilities subindustry, Greenbrook TMS's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenbrook TMS's Short Interest Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Greenbrook TMS's Short Interest distribution charts can be found below:

* The bar in red indicates where Greenbrook TMS's Short Interest falls into.

Greenbrook TMS (Greenbrook TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.